immunology

Events

Partner Content

Immuno-Oncology

Immuno-Oncology Main Conference: 26 – 27 September 2018 Pre-Conference Workshops: 25 September 2018 Copthorne Tara Hotel, London, UK

News

Escalier raises $19m to fund novel psoriasis pill

Escalier Biosciences, a privately-held biopharma company based in The Netherlands, has raised $19 million to help advance its pipeline.

News

one of many. Many of the same bottle, with a focus on one of them.

Janssen's RA candidate among hot topics at EULAR

But attendees warned to expect "oceanic" weather.

News

Samsung Bioepis' Remicade rival approved in EU

Merck, Sharp and Dohme's (MSD) inflammatory diseases blockbuster Remicade (infliximab) faces further biosimilar competition after Samsung Bioepis' rival, Flixabi, was approved in Europe.

Immuno-Oncology

Escalier raises $19m to fund novel psoriasis pill

Janssen's RA candidate among hot topics at EULAR

Samsung Bioepis' Remicade rival approved in EU

Consolidating data strategy for global success: Insights fro...

How to meet your physicians where they are online

immunology

Editor's Picks